Related Experiment Video
Updated: Jul 31, 2025
09:33
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
Renal primitive neuroectodermal tumor: A rare case with a good prognosis
Hanmin Chen1, Yanmin Li1, Qingming Zeng1
1Department of Urology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Frontiers in Surgery
|May 8, 2023
Summary
Renal primitive neuroectodermal tumors (rPNET) are aggressive but early surgical removal in non-metastatic cases offers a good prognosis. This case study highlights successful outcomes with radical nephrectomy alone.
Area of Science:
- Oncology
- Urologic Oncology
- Pediatric Oncology
Background:
- Renal primitive neuroectodermal tumor (rPNET) presents diagnostic challenges and aggressive behavior.
- rPNET is associated with high malignancy, early metastasis, and poor prognosis.
- Non-metastatic rPNET may achieve favorable survival with radical surgical resection.
Purpose of the Study:
- To report a case of a 14-year-old male with rPNET.
- To evaluate the outcome of radical nephrectomy without adjuvant therapy for non-metastatic rPNET.
- To emphasize the prognostic significance of surgical intervention in rPNET.
Main Methods:
- Case report of a 14-year-old male with a renal tumor.
- Open radical left nephrectomy performed.
- Postoperative follow-up included CT scans, urinalysis, and renal function tests.
Main Results:
- Pathological results confirmed rPNET.
- No adjuvant radiotherapy or chemotherapy was administered.
- No tumor recurrence or metastasis observed during nearly 5 years of follow-up.
Conclusions:
- Radical surgery is crucial for favorable outcomes in non-metastatic rPNET.
- Timely surgical resection can lead to good survival prognosis despite tumor malignancy.
- rPNET management underscores the importance of surgical intervention.
